25 Years of Successful Diazoxide and Trichlormethiazide Treatment of Hyperinsulinism in a 79-Year-Old Woman

J. C. Hoffmann, C. B. Cook, J. C. Floyd

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This paper reports the case of a 79-year-old woman who has been treated for 25 years with diazoxide and trichlormethiazide for continuing hyperinsulinism after an unsuccessful operation for a probable insulinoma. Episodes of confusion and a grand mal seizure associated with hypoglycaemia led to the demonstration of fasting hyperinsulinism [an immunoreactive insulin (IRI): blood glucose (G) ratio of > 0.30 or the ‘amended’ IRI: G ratio of > 49]. Two overnight fasts performed preoperatively and 8 performed postoperatively during the period from 1966 to 1989 confirmed continuing hyperinsulinism causing fasting hypoglycaemia, the need for continuing postoperative therapy, and the ongoing effectiveness of diazoxide and trichlormethiazide. Hyperinsulinism and associated hypoglycaemia have remained well controlled with these agents. Side effects have been minimal despite the long duration of therapy; advancing age has not been a contraindication to therapy. This treatment can be used effectively and safely for prolonged periods without loss of efficacy and without significant side effects in individuals with persistent hyperinsulinism as a result of benign insulinoma.

Original languageEnglish (US)
Pages (from-to)230-233
Number of pages4
JournalDrug Investigation
Volume3
Issue number4
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Trichlormethiazide
Diazoxide
Hyperinsulinism
Hypoglycemia
Insulinoma
Insulin
Therapeutics
Confusion
Blood Glucose
Fasting
Seizures

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

25 Years of Successful Diazoxide and Trichlormethiazide Treatment of Hyperinsulinism in a 79-Year-Old Woman. / Hoffmann, J. C.; Cook, C. B.; Floyd, J. C.

In: Drug Investigation, Vol. 3, No. 4, 01.01.1991, p. 230-233.

Research output: Contribution to journalArticle

Hoffmann, J. C. ; Cook, C. B. ; Floyd, J. C. / 25 Years of Successful Diazoxide and Trichlormethiazide Treatment of Hyperinsulinism in a 79-Year-Old Woman. In: Drug Investigation. 1991 ; Vol. 3, No. 4. pp. 230-233.
@article{7460e5b927c548d09252a091b17f56dd,
title = "25 Years of Successful Diazoxide and Trichlormethiazide Treatment of Hyperinsulinism in a 79-Year-Old Woman",
abstract = "This paper reports the case of a 79-year-old woman who has been treated for 25 years with diazoxide and trichlormethiazide for continuing hyperinsulinism after an unsuccessful operation for a probable insulinoma. Episodes of confusion and a grand mal seizure associated with hypoglycaemia led to the demonstration of fasting hyperinsulinism [an immunoreactive insulin (IRI): blood glucose (G) ratio of > 0.30 or the ‘amended’ IRI: G ratio of > 49]. Two overnight fasts performed preoperatively and 8 performed postoperatively during the period from 1966 to 1989 confirmed continuing hyperinsulinism causing fasting hypoglycaemia, the need for continuing postoperative therapy, and the ongoing effectiveness of diazoxide and trichlormethiazide. Hyperinsulinism and associated hypoglycaemia have remained well controlled with these agents. Side effects have been minimal despite the long duration of therapy; advancing age has not been a contraindication to therapy. This treatment can be used effectively and safely for prolonged periods without loss of efficacy and without significant side effects in individuals with persistent hyperinsulinism as a result of benign insulinoma.",
author = "Hoffmann, {J. C.} and Cook, {C. B.} and Floyd, {J. C.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1007/BF03259570",
language = "English (US)",
volume = "3",
pages = "230--233",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "4",

}

TY - JOUR

T1 - 25 Years of Successful Diazoxide and Trichlormethiazide Treatment of Hyperinsulinism in a 79-Year-Old Woman

AU - Hoffmann, J. C.

AU - Cook, C. B.

AU - Floyd, J. C.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - This paper reports the case of a 79-year-old woman who has been treated for 25 years with diazoxide and trichlormethiazide for continuing hyperinsulinism after an unsuccessful operation for a probable insulinoma. Episodes of confusion and a grand mal seizure associated with hypoglycaemia led to the demonstration of fasting hyperinsulinism [an immunoreactive insulin (IRI): blood glucose (G) ratio of > 0.30 or the ‘amended’ IRI: G ratio of > 49]. Two overnight fasts performed preoperatively and 8 performed postoperatively during the period from 1966 to 1989 confirmed continuing hyperinsulinism causing fasting hypoglycaemia, the need for continuing postoperative therapy, and the ongoing effectiveness of diazoxide and trichlormethiazide. Hyperinsulinism and associated hypoglycaemia have remained well controlled with these agents. Side effects have been minimal despite the long duration of therapy; advancing age has not been a contraindication to therapy. This treatment can be used effectively and safely for prolonged periods without loss of efficacy and without significant side effects in individuals with persistent hyperinsulinism as a result of benign insulinoma.

AB - This paper reports the case of a 79-year-old woman who has been treated for 25 years with diazoxide and trichlormethiazide for continuing hyperinsulinism after an unsuccessful operation for a probable insulinoma. Episodes of confusion and a grand mal seizure associated with hypoglycaemia led to the demonstration of fasting hyperinsulinism [an immunoreactive insulin (IRI): blood glucose (G) ratio of > 0.30 or the ‘amended’ IRI: G ratio of > 49]. Two overnight fasts performed preoperatively and 8 performed postoperatively during the period from 1966 to 1989 confirmed continuing hyperinsulinism causing fasting hypoglycaemia, the need for continuing postoperative therapy, and the ongoing effectiveness of diazoxide and trichlormethiazide. Hyperinsulinism and associated hypoglycaemia have remained well controlled with these agents. Side effects have been minimal despite the long duration of therapy; advancing age has not been a contraindication to therapy. This treatment can be used effectively and safely for prolonged periods without loss of efficacy and without significant side effects in individuals with persistent hyperinsulinism as a result of benign insulinoma.

UR - http://www.scopus.com/inward/record.url?scp=0025945854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025945854&partnerID=8YFLogxK

U2 - 10.1007/BF03259570

DO - 10.1007/BF03259570

M3 - Article

VL - 3

SP - 230

EP - 233

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 4

ER -